Stiffness of the large arteries in individuals with and without Down syndrome

Anabel N Rodrigues, Luan Cesar Coelho, Washington L S Goncalves, Sonia Alves Gouvea, Maria José Rossi Vasconcellos, Roberto S Cunha, Glaucia R Abreu, Anabel N Rodrigues, Luan Cesar Coelho, Washington L S Goncalves, Sonia Alves Gouvea, Maria José Rossi Vasconcellos, Roberto S Cunha, Glaucia R Abreu

Abstract

Background: Down syndrome is known to cause premature aging in several organ systems. However, it remains unclear whether this aging effect also affects the structure and function of the large arterial trunks. In this controlled study, the possibility of changes in the large arteries due to aging was evaluated in patients with Down syndrome.

Methods: Eighty-two subjects of both genders were selected. The Down syndrome group had 41 active subjects consisting of 19 males and 22 females (mean age 21 ± 1, range 13-42 years) without cardiovascular complications and who did not use vasoactive drugs. The control group consisted of 41 healthy individuals without trisomy 21 of the same gender and age as the Down syndrome group and who did not use vasoactive medication. Carotid-femoral pulse wave velocity was obtained as an index of aortic stiffness using an automatic noninvasive method.

Results: Individuals with Down syndrome had significantly lower blood pressure than those in the control group. Systolic blood pressure for the Down syndrome group and control group was 106 ± 2 mmHg vs 117 ± 2 mmHg (P < 0.001), respectively; diastolic blood pressure was 66 ± 2 mmHg vs 77 ± 2 mmHg (P < 0.001); and mean arterial pressure was 80 ± 1 mmHg vs 90 ± 1 mmHg (P < 0.001). Only age and systolic blood pressure were shown to correlate significantly with pulse wave velocity, but the slopes of the linear regression curves of these two variables showed no significant difference between the two study groups. Pulse wave velocity, which was initially significantly lower in the Down syndrome group (7.51 ± 0.14 m/s vs 7.84 ± 0.12 m/s; P <0.05), was similar between the groups after systolic blood pressure adjustment (7.62 ± 0.13 m/s vs 7.73 ± 0.13 m/s).

Conclusion: Despite evidence in the literature that patients with Down syndrome undergo early aging, this process does not seem to affect the large arterial trunks, given that values of carotid-femoral pulse wave velocity were similar in individuals with or without trisomy 21. Considering that Down syndrome presents with chronic hypotension, it is reasonable to propose that the prolonged reduction of arterial distending pressure may contribute to functional preservation of the arteries in patients with Down syndrome.

Keywords: Down syndrome; aging; arterial stiffness; pulse wave velocity.

Figures

Figure 1
Figure 1
Multivariate linear regression model with Pearson’s correlation coefficient between age, systolic blood pressure, and carotid–femoral pulse wave velocity in controls and subjects with Down syndrome.

References

    1. Safar ME, Toto-Moukou JJ, Bouthier JA, et al. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation. 1987;75:156–161.
    1. Safar ME. Therapeutic trials and large arteries in hypertension. Am Heart J. 1988;115:702–710.
    1. Safar ME, London G, Asmar RG, et al. Recent advances on large arteries in hypertension. Hypertension. 1998;32:156–161.
    1. Blacher J, Asmar R, Djane S, et al. Aortic pulse velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension. 1999;33:1111–1117.
    1. Lehmann ED. Clinical value of aortic pulse-wave velocity measurement. Lancet. 1999;354:528–529.
    1. Hamet P, Thorin-Trescasesn N, Moreau P, et al. Excess growth and apoptosis. Is hypertension a case of accelerated aging of cardiovascular cells. Hypertension. 2001;37:760–766.
    1. Von Zglinicki T. Telomeres: Influencing the rate of aging. Ann N Y Acad Sci. 1998;854:318–327.
    1. Reddel RR. A reassessment of the telomere hypothesis of senescence. BioEssays. 1998;20:977–984.
    1. Cunha RS, Benetos A, Laurent S, Safar ME, Asmar RG. Distension capacity of the carotid artery and ambulatory blood pressure monitoring: Effects of age and hypertension. Am J Hypertens. 1995;8:343–352.
    1. Smulyan H, Marchais SJ, Pannier B, et al. Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol. 1998;31:1103–1109.
    1. Avolio A, Jones D, Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in the arterial media. Hypertension. 1998;32:170–175.
    1. Cunha RS, Dabire H, Bezie Y, et al. Mechanical stress of the carotid artery at the early phase of spontaneous hypertension in rats. Hypertension. 1997;29:992–998.
    1. Lakatta EG. Arterial pressure and aging. Int J Cardiol. 1989;25:S81–S89.
    1. Nakamura E, Tanaka S. Biological ages of adult men and women with Down’s syndrome and its changes with aging. MechAgeing Dev. 1998;105:89–103.
    1. Comfort A. Test-battery to measure ageing-rate in man. Lancet. 1969;27:1411–1415.
    1. Hofecker G, Skalicky M, Kment A, et al. Models of the biological age of the rat. I. A factor model of age parameters. Mech Ageing Dev. 1980;14:345–359.
    1. Haynes A, Batshaw M. Down syndrome. Pediatr Clin North Am. 1993;40:523–535.
    1. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Hypertension. 1995;26:485–490.
    1. Murdoch JC, Roger JCH, Rao SS, et al. Down syndrome: An atheroma free model? Br Med J. 1977;2:226–228.
    1. Morrison RA, McGrath A, Davidson G, et al. Low blood pressure in Down’s syndrome, a link with Alzheimer’s disease? Hypertension. 1996;28:569–575.
    1. Yang Q, Rasmussem SA, Friedman JM, et al. Mortality associated with Down’s syndrome in the USA from 1983 to 1997: A population-based study. Lancet. 2002;359:1019–1025.
    1. Yla-Herttuala S, Luoma J, Nikkari T, et al. Down syndrome and atherosclerosis. Atherosclerosis. 1989;76:269–272.
    1. Goyal P, Singh R, Yadav A, et al. Dyslipidemia and superoxide dismutase activity in children with Down syndrome. J Nepal Pediatr Soc. 2010;30:160–163.
    1. Bortolotto LA, Blacher J, Kondo T, et al. Assessment of vascular aging and atherosclerosis in hypertensive subjects: Second derivative of photoplethysmogram versus pulse wave velocity. Am J Hypertens. 2000;13:165–171.
    1. Lehman ED. Noninvasive measurements of aortic stiffness: Methodological considerations. Pathol Biol (Paris) 1999;47:716–730. French.
    1. Ganong WF. Review of Medical Physiology. 17th ed. East Norwalk, CT: Appleton and Lange; 1995.
    1. Osiewacz HD, Hamann A. DNA reorganization and biological aging. A review. Biochemistry (Mosc) 1997;62:1275–1284.
    1. Folkow B, Svanborg A. Physiology of cardiovascular aging. Physiol Rev. 1993;73:725–764.
    1. O’Rourke MF, Mancia G. Arterial stiffness. J Hypertens. 1999;17:1–4.
    1. Arnett DK, Evans GW, Riley WA. Arterial stiffness: A new cardiovascular risk factor? Am J Epidemiol. 1994;140:669–682.
    1. Avoilo AP, Fa-quan D, Wei-Quiang L, et al. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension comparison between urban and rural communities in China. Circulation. 1985;71:202–210.
    1. Bland J, Altman G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;88:307–322.
    1. Benetos A, Topouchian J, Richard S, et al. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never treated hypertensive patients. Hypertension. 1995;26:44–47.
    1. Benetos A, Gautier S, Richard S. Influence of angiotensin II type 1 receptor gene polymorphism on aortic stiffness in normotensive and hypertensive patients. Circulation. 1996;94:698–703.
    1. London GM, Guerin AP, Pannier B, et al. Influence of sex on arterial hemodynamics and blood pressure. Role of body-height. Hypertension. 1995;26:514–519.
    1. Toto-Moukouo JJ, Achimastos A, Asmar RG, et al. Pulse wave velocity in patients with obesity and hypertension. Am Heart J. 1986;1120:136–140.
    1. Sharav T, Bowman T. Dietary practices, physical activity, and body-mass index in a selected population of Down syndrome children and their siblings. Clin Pediatr. 1992;31:341–344.
    1. Avolio A. Genetic and environmental factors in the function and structure of the arterial wall. Hypertension. 1995;26:34–37.
    1. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1999;32:560–564.
    1. Morcet JF, Safar M, Thomas F, et al. Associations between rate and other risk factors in a large French population. J Hypertens. 1999;17:1671–1676.
    1. London GM, Safar ME. Arterial wall remodeling and stiffness in hypertension: Heterogeneous aspects. Clin Exp Pharmacol Physiol. 1996;23:S1–S5.
    1. Richards BW, Enver F. Blood pressure in Down’s syndrome. J Ment Defic Res. 1979;23:123–133.
    1. Russo MA, Pacileo G, Marino B, et al. Echocardiographic evaluation of left ventricular systolic function in the Down syndrome. Am J Cardiol. 1998;81:1215–1217.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera